The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.
Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain
Open accessAbstract
Proteins with intrinsically disordered domains are implicated in a vast range of biological processes, especially in cell signaling and regulation. Having solved the quaternary structure of the folded domains in the tumor suppressor p53 by a multidisciplinary approach, we have now determined the average ensemble structure of the intrinsically disordered N-terminal transactivation domain (TAD) by using residual dipolar couplings (RDCs) from NMR spectroscopy and small-angle x-ray scattering (SAXS). Remarkably, not only were we able to measure RDCs of the isolated TAD, but we were also able to do so for the TAD in both the full-length tetrameric p53 protein and in its complex with a specific DNA response element. We determined the orientation of the TAD ensemble relative to the core domain, found that the TAD was stiffer in the proline-rich region (residues 64–92), which has a tendency to adopt a polyproline II (PPII) structure, and projected the TAD away from the core. We located the TAD in SAXS experiments on a complex between tetrameric p53 and four Taz2 domains that bind tightly to the TAD (residues 1–57) and acted as “reporters.” The p53-Taz2 complex was an extended cross-shaped structure. The quality of the SAXS data enabled us to model the disordered termini and the folded domains in the complex with DNA. The core domains enveloped the response element in the center of the molecule, with the Taz2-bound TADs projecting outward from the core.
Overview
CoChat Summary
TL;DR
Using NMR residual dipolar couplings (RDCs) and small-angle x-ray scattering (SAXS), the authors characterized the intrinsically disordered N-terminal domain of p53 and modeled its ensemble in isolated, full-length, DNA-bound, and Taz2-bound states. They found a stiff proline-rich region that projects the transactivation domain outward and a transient helical element in the TAD.
Key findings
- Isolated p53(1–93) is disordered with nascent structure: residues 22–25 adopt a helical conformation populated at ≈30%, and the proline-rich region (PRR, residues 64–92) shows elevated polyproline II (PPII) propensity, with optimal RDC-derived populations of 79 ± 2% for proline and 50 ± 2% for preproline residues, close to accelerated MD predictions of 78 ± 3% and 46 ± 4%.
- The PRR is stiffer than the TAD and projects the TAD away from the core domain; SAXS data for p53(1–93) were reproduced by the RDC-derived ensemble and were not consistent with a collapsed TAD.
- RDCs from the TAD were measured in isolated p53(1–93), full-length tetrameric p53, and p53–DNA; in DNA-bound flp53 the TAD couplings were smaller and PRR couplings larger, whereas DNA-free RDCs were similar to isolated p53(1–93) except for smaller PRR values.
- SAXS showed the flp53–Taz2 complex has four Taz2 domains per tetramer and is an extended cross-shaped structure fitted with χ = 1.19; a ternary flp53–Taz2–DNA model fitted with χ = 2.0, with Taz2-bound TADs projecting outward from the core and core domains enveloping the response element.
Methods
- RDC NMR experiments used strained polyacrylamide gel and pf1 bacteriophage alignment at 20°C on isolated p53(1–93), a full-length p53 quadruple mutant, p53(1–393)–DNA, and synthetic 15N-labeled peptides comprising residues 61–93; measured couplings included 1DNHN, 2DC′HN, 1DC′Cα, 1DCαHα, and 3JHαHN.
- SAXS data were collected at the X33 beamline at EMBL/DESY, Hamburg; p53(1–93) samples ranged from 2 to 8.6 mg/ml; data were processed with PRIMUS and modeled with ATSAS programs CRYSOL, SASREF, and BUNCH, including rigid-body refinement using the Taz2 structure PDB 1F81.
- Conformational ensembles were generated with flexible-meccano sampling of coil-library propensities and accelerated MD simulations (AMBER8) for PRR residues 70–82; 50,000 tetramer structures were built with four independent N-terminal chains (200,000 chains total), and RDCs were predicted and averaged over the ensemble.
Limitations
- Stated: modeling the N terminus in the context of DNA-free flp53, which contains several rigid bodies in a highly dynamic state, was beyond the scope of the study; the absolute level of alignment is difficult to predict from simulation; and SAXS reproduction deviated at q < 0.04, where experimental values were higher than predicted.
- Evident: conclusions about the disordered N-terminal domain rely on ensemble and rigid-body models fitted to solution RDC/SAXS data rather than single high-resolution structures; the models are described as probably representative of dynamic ensembles, so conformational heterogeneity may not be fully resolved.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 15 Not checked · 42 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An important finding is that the PRR exhibits an elevated degree of stiffness.”
- Also stated in: § Conclusions · plain
“The PRR, attached to the folded core domain, exhibits enhanced stiffness relative to the TAD”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusions · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we have now determined the average ensemble structure of the intrinsically disordered N-terminal transactivation domain (TAD) by using residual dipolar couplings (RDCs) from NMR spectroscopy and small-angle x-ray scattering (SAXS).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The core domains enveloped the response element in the center of the molecule, with the Taz2-bound TADs projecting outward from the core.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and projected the TAD away from the core”
- Also stated in: § Abstract · plain
“where the proline-rich region can be seen to preferentially project the chain away from the core domain, thereby defining the volume space occupied by the flexible TAD.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The p53-Taz2 complex was an extended cross-shaped structure.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
34 more claims
Create a free account to see all 57 claims and to verify the 26 references still open.
- It may state two separate claims as one. 15
- Probably not a substantial claim. 4
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Abstract
“the transactivation domain (TAD) comprising the first 58 aa”
§ Abstract
“TAD (residues 1–57)”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Svergun, D., Barberato, C., & Koch, M. H. J. (1995) · Journal of Applied Crystallography · doi:10.1107/s0021889895007047 · Cited by 3,434
Self-citationPRIMUS: a Windows PC-based system for small-angle scattering data analysis
Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J., & Svergun, D. I. (2003) · Journal of Applied Crystallography · doi:10.1107/s0021889803012779 · Cited by 2,879
Self-citationCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 1×
“The first step is to solve the structures of individual core domains by using x-ray crystallography (6, 7) and NMR (8–10).”
BackgroundStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
New developments in the ATSAS program package for small-angle scattering data analysis
Petoukhov, M. V., Franke, D., Shkumatov, A. V., Tria, G., Kikhney, A. G., Gajda, M., Gorba, C., Mertens, H. D. T., Konarev, P. V., & Svergun, D. I. (2012) · Journal of Applied Crystallography · doi:10.1107/s0021889812007662 · Cited by 1,903
Self-citationTjandra, N., & Bax, A. (1997) · Science · doi:10.1126/science.278.5340.1111 · Cited by 1,719
Intrinsic Disorder in Cell-signaling and Cancer-associated Proteins
Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradović, Z., & Dunker, A. K. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00969-5 · Cited by 1,214
Vuister, G. W., & Bax, A. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00070a024 · Cited by 978
Global Rigid Body Modeling of Macromolecular Complexes against Small-Angle Scattering Data
Petoukhov, M. V., & Svergun, D. I. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.064154 · Cited by 899
Self-citation
Research works printed but not linked: 1
- DA Case, et al. AMBER 8 (Univ of California, San Francisco, 2004).
Cited by
Intrinsically disordered proteins in cellular signalling and regulation
Wright, P. E., & Dyson, H. J. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3920 · Cited by 2,401
Das, R. K., & Pappu, R. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304749110 · Cited by 1,023
Wright, P. E., & Dyson, H. J. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.003 · Cited by 1,019
Kikhney, A. G., & Svergun, D. I. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.027 · Cited by 693
Self-citationThe p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Joerger, A. C., & Fersht, A. R. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014710 · Cited by 661
Self-citation
Metadata
- Authors
- Wells, M., Tidow, H., Rutherford, T. J., Markwick, P., Jensen, M. R., Mylonas, E., Svergun, D. I., Blackledge, M., & Fersht, A. R.
- Affiliations
- *MRC Centre for Protein Engineering, Hills Road, Cambridge CB2 0QH, United Kingdom;
- Centre National de la Recherche Scientifique (FR)
- Institut de Biologie Structurale Jean-Pierre Ebel, Unité Mixte de Recherche 5075, Centre National de la Recherche Scientifique/Commissariat à l'Energie Atomique/Université Joseph Fourier, 41 Rue Jules Horowitz, 38027 Grenoble, France
- European Molecular Biology Laboratory (DE)
- Russian Academy of Sciences (RU)
- Corresponding author
- Blackledge, Martin
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-04-15
- Volume
- 105
- Issue
- 15
- Pages
- 5762-5767
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2311362
- OpenAlex
- W2149573413
- Semantic Scholar
- 2ff8b142682cbbbe53a3c53201518876389d844f
- Cited by
- 434
- References
- 52
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 14 · 2023: 19 · 2022: 20 · 2021: 24 · 2020: 28 · 2019: 25 · 2018: 31 · 2017: 26 · 2016: 23 · 2015: 20 · 2014: 30 · 2013: 28 · 2012: 38
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- HAL (submittedVersion)
- DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron) (submittedVersion, other-oa)
- Funders
- Boehringer Ingelheim Fonds
- Agence Nationale de la Recherche
- Medical Research Council
- Deutsches Elektronen-Synchrotron (RII3/CT/2004/5060008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- p53, intrinsically disordered regions, N-terminal transactivation domain, quaternary structure, residual dipolar couplings, small-angle X-ray scattering, proline-rich region, tumor suppressor
- MeSH terms
- DNA, Humans, Mutation, Peptide Fragments, Protein Binding, X-Ray Diffraction, Transcriptional Activation, Tumor Suppressor Protein p53, Protein Structure, Tertiary, Response Elements, Amino Acid Motifs, Scattering, Small Angle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. https://app.cochat.ai/papers/10.1073/pnas.0801353105
- The paper
- Wells, M., Tidow, H., Rutherford, T. J., Markwick, P., Jensen, M. R., Mylonas, E., Svergun, D. I., Blackledge, M., & Fersht, A. R. (2008). Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0801353105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.